The trial did fail, and the evidence is overwhelming. That's why about five or six years ago, after they conducted an IA and the FDA banned anyone else from participating in their trial, they suddenly went quiet. Only when asked about it directly did they say anything, and that's when they very craftily and strategically started mentioning this grand concept called the "long tail" and employed their bulletin board platoon to start calling the "long tail" the "gold standard" of GBM vaccine endpoints. What's odd, though, is that when they set up their own Phase 3 trial for DCVax-L, they did not use the supposed "gold standard" for their primary endpoint. No, they used PFS as their primary endpoint, and if you go to clinicaltrials.gov today you will see that it is still listed as such. The trial measurement components on clinicaltrials.gov don't say anything about long tails.
By pure coincidence, they also began lobbying the FDA to consider the hardships of poor little bio-startups whose trials happen to fail the PFS endpoint - yes, the same PFS that they themselves had set as the primary measurement component of the trial. Funny they would ask the FDA for that kind of leniency. Now why would they do that? Perhaps to help out potential competitors whose trials fail PFS? Now that would really be something, but, no, I don't think that's why. If you really think on it hard, you eventually stumble on the conclusion that they were probably asking the FDA for leniency because they know their own trial is a PFS failure.
Anyone with half a brain knows that if the trial had shown progress toward meeting the primary PFS endpoint, they would have ended the trial in 2015 and declared DCVax-L a great success. But they didn't. Instead, they went totally silent and tried to surreptitiously change the whole focus of the trial. It was at that point that this whole debacle became an outright scam because since that time all they have done is raise money to pay themselves $500,000 salaries, cut insider loan, warrant and real estate deals that have allowed them to pocket millions, dilute our stock with pump-and-dump schemes to pay off their buddies, and totally destroy the value of common shareholders' investments. And the whole time they've been laughing at you, daring you to do something about it. They lie with impunity and say things like we expect data lock to occur approximately by the end of May as a distraction while the reality is that behind the scenes all they were doing was preparing to unload another pump-and-dump payoff for their buddies. It's why they continue to miss financial reporting deadlines even after being rebuked by the SEC to clean up their act. Lying with impunity and incessant distractions are common characteristics of all scams.
Make no mistake. The evidence is overwhelming that this trial did fail. It is more than just a rumor.
